BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33383242)

  • 1. On-line separation and quantification of virus antigens of different serotypes in multivalent vaccines by capillary zone electrophoresis: A case study for quality control of foot-and-mouth disease virus vaccines.
    Song Y; Yang Y; Lin X; Zhao Q; Li Z; Ma G; Su Z; Zhang S
    J Chromatogr A; 2021 Jan; 1637():461834. PubMed ID: 33383242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
    Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
    Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes.
    Grant CFJ; Carr BV; Kotecha A; van den Born E; Stuart DI; Hammond JA; Charleston B
    J Virol; 2017 May; 91(9):. PubMed ID: 28228594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Rapid Antigen Detection and Serotyping Lateral Flow Antigen Detection System for Foot-and-Mouth Disease Virus.
    Morioka K; Fukai K; Yoshida K; Kitano R; Yamazoe R; Yamada M; Nishi T; Kanno T
    PLoS One; 2015; 10(8):e0134931. PubMed ID: 26270053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
    Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs.
    Chockalingam AK; Thiyagarajan S; Govindasamy N; Patnaikuni R; Garlapati S; Golla RR; Joyappa DH; Krishnamshetty P; Veluvarti VV
    Acta Virol; 2010; 54(3):189-95. PubMed ID: 20822311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype-independent detection of foot-and-mouth disease virus.
    Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
    J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction, Expression and Evaluation of Recombinant VP2 Protein for serotype-independent Detection of FMDV Seropositive Animals in Egypt.
    Salem R; El-Kholy AA; Omar OA; Abu El-Naga MN; Ibrahim M; Osman G
    Sci Rep; 2019 Jul; 9(1):10135. PubMed ID: 31300744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig.
    Yi JZ; Liu MQ; Zhu CZ; Zhang Q; Sheng ZT; Du QY; Yan WY; Zheng ZX
    Acta Biochim Biophys Sin (Shanghai); 2004 Sep; 36(9):589-96. PubMed ID: 15346195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and inhibition of abnormal chromatographic behavior of serotype type a inactivated foot and mouth disease virus in high-performance size-exclusion chromatography.
    Yang Y; Li M; Zhao Y; Lin X; Su Z; Xin F; Du X; Zheng K; Han R; Pan Y; He S; Zhang S
    J Chromatogr A; 2022 Dec; 1686():463648. PubMed ID: 36410170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes.
    Joshi G; Sharma R; Kakker NK
    Vaccine; 2009 Nov; 27(48):6656-61. PubMed ID: 19751690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.